# Meusinvest (Noshaq)

> Meusinvest (Noshaq) is a VC fund backing Biotechnology and Health Care. See 78 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Liège, Belgium
- Total investments: 78
- Last investment: Jul 2025
- Lead investor: 10%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/meusinvest
- X (Twitter): http://twitter.com/meusinvest
- Website: http://www.meusinvest.be
- Facebook: http://www.facebook.com/pages/Meusinvest/416072068450284

Meusinvest (Noshaq) is a VC fund in Liège focused on Biotechnology and Health Care. Noshaq offers financial services to help businesses develop.

## Contacts

5 contacts available for Meusinvest (Noshaq). Shizune tracks 3 team members at Meusinvest (Noshaq). Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/meusinvest?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $137k–$6M |
| Series A | $3.6M–$16M |
| Series B | $680k–$31M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 23 | 29% |
| Health Care | 20 | 26% |
| Medical | 11 | 14% |
| Health Diagnostics | 6 | 8% |
| Life Science | 5 | 6% |

86 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 21 | 27% |
| Seed | 20 | 26% |
| Venture - Series Unknown | 9 | 12% |
| Series B | 8 | 10% |
| Funding Round | 6 | 8% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Belgium | 39 | 50% |
| France | 14 | 18% |
| Germany | 2 | 3% |
| United Kingdom | 2 | 3% |
| Luxembourg | 1 | 1% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alain Balthazart | Investment Manager | 1 | https://shizune.co/investors/profile/alain-balthazart |
| Gérôme Vanherf | Program Manager | 0 | https://shizune.co/investors/profile/g%C3%A9r%C3%B4me-vanherf |
| Joanna Tyrekidis | CEO of Noshaq Spin-Offs; Investment Manager | 1 | https://shizune.co/investors/profile/joanna-tyrekidis |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Allegro Biotech | Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells). | $2.4M | Seed | Jul 03, 2025 |  |
| Le Fourgon | Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day. | $5.9M | Series A | Jan 30, 2025 |  |
| TrustUp | TrustUp is the home contractors platform, connects homeowners with verified quality home improvement. | $5.2M | Series A | Jan 01, 2025 |  |
| Veoware | Veoware provides Space satellite imagery services. | $2.8M | Venture - Series Unknown | Sep 19, 2024 |  |
| Brenus Pharma | Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $25M | Series A | Sep 18, 2024 |  |
| Get Your Way | Get Your Way has redesigned connected glasses for assisted reality in the industry with a frugal innovation approach. It allows to open up to new customer segments, new applications and to be widely applicable. We have removed the barriers to the adoption of connected glasses in the industry: cost, comfort, and user interest. | $945.6K | Venture - Series Unknown | Aug 28, 2024 |  |
| Hedera-22 | Hedera-22 expanded its scope to include the identification of natural products through the use of in-house bio-informatic prediction technologies. | $2.2M | Venture - Series Unknown | Aug 14, 2024 |  |
| SamanTree Medical | SamanTree Medical is a swiss innovative medical device company providing a breakthrough imaging solution with the potential to improve patient care and cancer surgery outcome. Based on confocal microscopy, SamanTree Medical’s solution brings accurate and full margin control by the surgeon, in the operating room. | $14M | Series B | Jul 16, 2024 |  |
| MYOCENE | Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance. | $3.2M | Seed | Jun 18, 2024 |  |
| Novobiom | Bioremediation for persistant and pervasive pollutants | $2.1M | Seed | May 01, 2024 |  |

10 of 78 investments shown.

## Co-investors
- [S.R.I.W.](https://shizune.co/investors/profile/s-r-i-w) — VC Fund, 10 deals together
- [LeanSquare](https://shizune.co/investors/profile/leansquare) — VC Fund, 9 deals together
- [SFPI-FPIM](https://shizune.co/investors/profile/sfpi-fpim) — VC Fund, 8 deals together
- [WING by Digital Wallonia](https://shizune.co/investors/profile/w-in-g-wallonia-innovation-and-growth) — VC Fund, 7 deals together
- [Investsud](https://shizune.co/investors/profile/investsud) — VC Fund, 5 deals together
- [Sambrinvest](https://shizune.co/investors/profile/sambr-invest) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund

## Featured in investor lists
- [All Investors in Belgium](https://shizune.co/investors/investors-belgium)
- [All VC Funds in Belgium](https://shizune.co/investors/vc-funds-belgium)
- [Health Care Investors in Europe](https://shizune.co/investors/health-care-investors-europe)
- [Health Care VC Funds in Europe](https://shizune.co/investors/health-care-vc-funds-europe)
- [Biotechnology Investors in Europe](https://shizune.co/investors/biotechnology-investors-europe)
- [Biotechnology VC Funds in Europe](https://shizune.co/investors/biotechnology-vc-funds-europe)

## FAQ

### What does Meusinvest (Noshaq) invest in?

Meusinvest (Noshaq) invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 78 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Meusinvest (Noshaq)'s check size?

Meusinvest (Noshaq) typically joins rounds of $137k–$6M at Seed, $3.6M–$16M at Series A and $680k–$31M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Meusinvest (Noshaq) participates in.

### How do I contact Meusinvest (Noshaq)?

Public channels for Meusinvest (Noshaq) include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Meusinvest (Noshaq)?

The team at Meusinvest (Noshaq) includes Alain Balthazart (Investment Manager), Gérôme Vanherf (Program Manager) and Joanna Tyrekidis (CEO of Noshaq Spin-Offs; Investment Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co